While the company is showing early signs of recovery and margin improvement, a high valuation means risks remain.

Tariffs on medical supplies are causing delays, wait times, and increased costs for hospitals, and the president’s tariffs ...

GenAI is changing pharma operations. Explore real-world tools and use cases for AI in pharmaceutical industry workflows.

Smart technologies, such as digital and laser printing, incorporated into manufacturing equipment are helping manufacturers ...

We believe the top-line growth for AST will reach 10% as new plants in Illinois, California, and New York ramp up production. Given the current scale of Steris’ AST operations (close to $1 billion in ...

US drug companies are increasingly licensing experimental medicines invented by Chinese firms. The recent deals could be ...

In regulated industries like life sciences, quality and manufacturing have traditionally been built for assurance, not ...

That's great news for Nvidia and other frontline players in the AI/data center industry. It's also great news for some of the ...

Enhertu, Datroway and other antibody-drug conjugates developed by Daiichi Sankyo have made the company a leader in a ...

How Dynamic Risk Management Can Turn Chaos Into Opportunity. Forrester. The recent introduction of US-imposed tariffs has ...

Aizon and Sequence are pleased to announce a new strategic partnership aimed at delivering comprehensive, AI-powered ...